Market Place
Sourcing Support
Blue Earth Advances Lutetium rhPSMA-10.1 With Phase 1 Data
08 Oct 2024 //
PR NEWSWIRE
Blue Earth and Seibersdorf expand radiopharmaceutical manufacture deal
12 Aug 2024 //
PHARMACEUTICAL TECHNOLOGY
Blue Earth Partners With UCL On Alpha-RLT For Prostate Cancer
23 Jul 2024 //
BUSINESSWIRE
SHINE, BlueEarth Partner For First Ilumira Supply From New Facility
06 Jun 2024 //
PR NEWSWIRE
BET Announces Results from Preclinical Evaluation for the Prostate Cancer
08 Apr 2024 //
BUSINESSWIRE
Blue Earth Announces Participation in Upcoming B. Riley Investor Conference
28 Feb 2024 //
BUSINESSWIRE
Blue Earth Announces Publication of Results from Experience with 177Lu-rhPSMA-10.1
20 Feb 2024 //
BUSINESSWIRE
Blue Earth Announces Promising Results of Evaluation of 225Ac-rhPSMA-10.1
11 Sep 2023 //
BUSINESSWIRE
Blue Earth Announces Results of Early Clinical Studies of Invg 177Lu-rhPSMA-10.1
28 Jun 2023 //
BUSINESSWIRE
Blue Earth Therapeutics Highlights Presentations at Upcoming Society
20 Jun 2023 //
BUSINESSWIRE
Blue Earth Awarded UK MHRA Innovation Passport for InveG 177Lu-rhPSMA-10.1
08 Nov 2022 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.